Hinge Health has emerged as a notable tech IPO, focusing on providing digital musculoskeletal care through employers and health plans. They offer AI-driven motion tracking, exercise therapy, and FDA-approved pain relief devices, servicing over 2,300 enterprise clients, including 49% of the Fortune 100.
Hinge Health’s impressive recent performance:
- $556M ARR with 55% growth YoY
- Revenue growth is accelerating
- 83% non-GAAP gross margins (+600 bps)
- $130M FCF (23% FCF margin)
- 117% NDR and 98% client retention
With a $3.9B enterprise value, it trades at about 7x ARR.
The B2B2C platform achieved the Rule of 78 (55% growth + 23% FCF margin) with superior retention rates
Hinge Health is among the top tech IPOs of 2025, a year with 80% more IPOs than 2024, including notable offerings like Figma, CoreWeave, Circle, and Chime. This cohort focuses on combining growth with profitability, with Hinge Health showcasing exemplary Rule of 78 performance.
5 Key Insights
#1. Optimal NDR and Logo Retention Combo
The Numbers: 117% net dollar retention, 98% client retention, and annual yield expansion of 3.4%, leading to 52% billings growth to $507M LTM.
Leave a Reply